Millennium Management
HUMA icon

Millennium Management’s Humacyte HUMA Stock Holding History

Millennium Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.6K Sell
108,154
-2,523,836
-96% -$2.62M ﹤0.01% 5404
2025
Q4 		$2.53M Buy
2,631,990
+1,485,152
+129% +$2.1M ﹤0.01% 3734
2025
Q3 		$2M Sell
1,146,838
-1,406,109
-55% -$2.75M ﹤0.01% 4063
2025
Q2 		$5.34M Buy
2,552,947
+1,212,864
+91% +$2.33M ﹤0.01% 2920
2025
Q1 		$2.28M Buy
1,340,083
+421,229
+46% +$1.58M ﹤0.01% 3664
2024
Q4 		$4.64M Sell
918,854
-348,653
-28% -$1.73M ﹤0.01% 2879
2024
Q3 		$6.9M Sell
1,267,507
-331,800
-21% -$2.19M ﹤0.01% 2546
2024
Q2 		$7.68M Buy
1,599,307
+1,334,641
+504% +$6.95M ﹤0.01% 2325
2024
Q1 		$823K Sell
264,666
-1,030,700
-80% -$3.47M ﹤0.01% 4466
2023
Q4 		$3.68M Buy
1,295,366
+68,957
+6% +$177K ﹤0.01% 3056
2023
Q3 		$3.59M Buy
+1,226,409
New +$4.06M ﹤0.01% 3023
2023
Q2 		– Sell
-27,875
Closed -$86K – 6359
2023
Q1 		$86K Buy
+27,875
New +$79.3K ﹤0.01% 5471
2022
Q4 		– Sell
-423,880
Closed -$1.38M – 6756
2022
Q3 		$1.38M Buy
423,880
+25,115
+6% +$96.3K ﹤0.01% 4063
2022
Q2 		$1.28M Buy
398,765
+115,192
+41% +$640K ﹤0.01% 4149
2022
Q1 		$2M Buy
+283,573
New +$1.65M ﹤0.01% 3879
2021
Q3 		– Sell
-54,705
Closed -$557K – 6983
2021
Q2 		$557K Buy
54,705
+8,194
+18% +$84.4K ﹤0.01% 5210
2021
Q1 		$504K Buy
+46,511
New +$508K ﹤0.01% 4822

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Millennium Management's HUMA Position: Q1 2026 in Review

Millennium Management reduced its Humacyte (HUMA) stake by 96% in Q1 2026, selling an estimated $2.62M and leaving 108,154 shares worth $65.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5404.

Millennium Management first reported a position in HUMA in Q1 2021 and has held it in 17 quarters since. The position peaked at $7.68M in Q2 2024. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Millennium Management held 108,154 shares of Humacyte worth $65.6K as of Q1 2026.
  • Millennium Management sold 2,523,836 Humacyte shares in Q1 2026, an estimated $2.62M.
  • Humacyte made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5404 holding.
  • Millennium Management first reported a position in Humacyte in Q1 2021 and has held it in 17 quarters since.
  • Millennium Management's Humacyte position peaked at $7.68M in Q2 2024.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.